Amiodarone in congestive heart failure: unravelling the GESICA and CHF-STAT differences.
作者信息
Hammill S C, Packer D L
出版信息
Heart. 1996 Jan;75(1):6-7. doi: 10.1136/hrt.75.1.6.
Abstract
摘要
相似文献
1
Amiodarone in congestive heart failure: unravelling the GESICA and CHF-STAT differences.胺碘酮用于充血性心力衰竭：剖析GESICA研究与CHF-STAT研究的差异
Heart. 1996 Jan;75(1):6-7. doi: 10.1136/hrt.75.1.6.
2
Amiodarone: what have we learned from clinical trials?胺碘酮：我们从临床试验中学到了什么？
Clin Cardiol. 2000 Feb;23(2):73-82. doi: 10.1002/clc.4960230203.
3
Amiodarone in congestive heart failure.胺碘酮用于充血性心力衰竭
Int J Clin Pract. 1998 Sep;52(6):432-5.
4
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.胺碘酮或植入式心脏复律除颤器用于治疗充血性心力衰竭。
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.
5
[Amiodarone or ICD in patients with cardiac insufficiency. SCD-HeFT Study].
Internist (Berl). 2006 Jan;47(1):89-91. doi: 10.1007/s00108-005-1543-1.
6
Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).胺碘酮对心脏性猝死昼夜模式的影响（退伍军人事务部充血性心力衰竭抗心律失常治疗生存试验）
Am J Cardiol. 1997 Jul 1;80(1):45-8. doi: 10.1016/s0002-9149(97)00281-6.
7
Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina.心率是胺碘酮降低严重心力衰竭死亡率的一个指标。GESICA - GEMA研究人员。阿根廷心力衰竭生存研究小组 - 阿根廷多中心研究小组。
J Am Coll Cardiol. 1997 May;29(6):1199-205. doi: 10.1016/s0735-1097(97)00066-1.
8
Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy.Ⅲ类药物与充血性心力衰竭：聚焦抗心律失常治疗的充血性心力衰竭生存试验
Am J Cardiol. 1999 Nov 4;84(9A):103R-108R. doi: 10.1016/s0002-9149(99)00710-9.
9
10
Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.预防性胺碘酮对急性心肌梗死后及充血性心力衰竭患者死亡率的影响：对随机试验中6500例患者个体数据的荟萃分析。胺碘酮试验荟萃分析研究人员。
Lancet. 1997 Nov 15;350(9089):1417-24.
引用本文的文献
1
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.胺碘酮与甲状腺：胺碘酮治疗所致甲状腺功能障碍管理实用指南
Heart. 1998 Feb;79(2):121-7. doi: 10.1136/hrt.79.2.121.
2
Optimal treatment of heart failure in the elderly.老年人心力衰竭的最佳治疗方法。
Drugs Aging. 1997 Jun;10(6):435-43. doi: 10.2165/00002512-199710060-00004.
本文引用的文献
1
Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.胺碘酮相关的致心律失常作用。特别提及尖端扭转型室性心动过速的综述。
Ann Intern Med. 1994 Oct 1;121(7):529-35. doi: 10.7326/0003-4819-121-7-199410010-00009.
2
Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).低剂量胺碘酮治疗重度充血性心力衰竭的随机试验。阿根廷心脏衰竭生存研究小组（GESICA）。
Lancet. 1994 Aug 20;344(8921):493-8. doi: 10.1016/s0140-6736(94)91895-3.
3
Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.胺碘酮用于充血性心力衰竭合并无症状室性心律失常患者。充血性心力衰竭抗心律失常治疗生存试验。
N Engl J Med. 1995 Jul 13;333(2):77-82. doi: 10.1056/NEJM199507133330201.
4
Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
Am Heart J. 1987 Mar;113(3):707-15. doi: 10.1016/0002-8703(87)90711-3.
5
Mortality in heart failure: clinical variables of prognostic value.心力衰竭中的死亡率：具有预后价值的临床变量。
Br Heart J. 1987 Dec;58(6):572-82. doi: 10.1136/hrt.58.6.572.
6
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).抗心律失常治疗对无症状复杂性室性心律失常的心肌梗死幸存者死亡率的影响：巴塞尔心肌梗死生存抗心律失常研究（BASIS）。
J Am Coll Cardiol. 1990 Dec;16(7):1711-8. doi: 10.1016/0735-1097(90)90324-i.
7
Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy.低剂量胺碘酮治疗重度心力衰竭合并无症状频发室性早搏的前瞻性、双盲、安慰剂对照试验
Am Heart J. 1991 Oct;122(4 Pt 1):1016-21. doi: 10.1016/0002-8703(91)90466-u.
8
Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.室性早搏患者心肌梗死后的死亡率。加拿大胺碘酮心肌梗死心律失常试验初步研究。
Circulation. 1991 Aug;84(2):550-7. doi: 10.1161/01.cir.84.2.550.
9
Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study.
J Am Coll Cardiol. 1992 Nov 1;20(5):1056-62. doi: 10.1016/0735-1097(92)90357-s.
Zotero 插件